Tracking PCT – a biomarker for bacterial infections – over time provides strong indication of likely mortality, enabling physicians to personalize care for high-risk patients
bioMérieux acquires Hyglos
bioMérieux acquires Hyglos and expands its offering to the detection of endotoxins in pharmaceutical products
bioMérieux and the Lyon Civil Hospitals strengthen their collaboration
bioMérieux and the Lyon Civil Hospitals strengthen their collaboration and expand their partnership to include Claude Bernard University Lyon 1 Two joint research laboratories focused on a common goal: advancing medical research for the benefit of patients
bioMérieux and Antwerp University unveil the final results of the first Global Point Prevalence Survey1 of antibiotic use and resistance rates in hospitals
Huge discrepancies in antibiotic use practices between countries 2nd line antibiotics2 too frequently prescribed
FilmArray® Torch is now FDA cleared with all 4 existing FilmArray® Panels and the system gets CE marked
BioFire receives FDA clearances for FilmArray® Torch with FilmArray® Blood Culture Identification Panel, Gastrointestinal Panel and Meningitis/Encephalitis Panel FilmArray® Torch delivers high throughput, radically smaller footprint
bioMérieux – 2015 Financial Results
BioFire Receives FDA Clearance for FilmArray® Torch with FilmArray® Respiratory Panel and Submits Special 510(k) Applications for Use with additional FilmArray® Panels
FilmArray® Torch delivers high throughput, radically smaller footprint
Fourth-Quarter 2015 Business Review
BioFire Submits Special 510(k) Application to the FDA for the use of FilmArray® Torch, the New High Throughput FilmArray® System with FilmArray® Respiratory Panel
FilmArray® Torch delivers high throughput, radically smaller footprint
BioFire’s FilmArray® Meningitis/Encephalitis Panel gets CE marked
FilmArray® expanded menu, with a fourth panel, is the largest available on a molecular biology multiplex platform